Scholars Central

Conference abstractPublished 24 Sep 2018

Identification of a miR-1245a germline variant and its relation with early-onset breast cancer susceptibility

Authors: Lilian Jara

University of Chile, Chile

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast Cancer (BC) is one of the most frequent cancers affecting women worldwide. In Chile, BC has the highest mortality rate among cancers (15.69/100,000 women). Recent evidence supports a role for microRNAs (miRNAs) in BC development and progression. Single-Nucleotide Polymorphisms (SNPs) are the most common type of variation in the human genome. SNPs in miRNA genes can alter expression, maturation or target binding affinity, thus contributing to the development of cancer. Studies have documented that SNPs in miRNA(s) targeting BRCA1/2 genes alter BRCA gene expression levels. miR- 1245a targets the BRCA2 gene. Sequencing pre-miR-1245a in 107 BRCA1/2-negative BC probands from high-risk families resulted in the identification of rs60611793, which corresponds to a 1-bp deletion. This variant was detected in an early-onset (diagnosis at 30 years of age), Triple-Negative (TN) BC case without a family history of BC. Given the clinic-pathological features of the patient carrying the deletion, we used Sanger sequencing to screen for rs60611793 in another 181 early-onset and TN BC cases and 192 healthy individuals. The deletion was detected in another four BC cases and 3 of 192 controls. The five cases with the deletion had early-onset BC. However, there was no correlation between rs60611793 and histological BC type. Two of the five cases were poorly-differentiated ductal carcinomas, one was a medullar carcinoma, one was an in-situ carcinoma and the histopathological report for the fifth case was unavailable. Therefore, this deletion could be related to the development of early-onset BC and high-grade malignant neoplasms, with no predominant ER/PR/Her2/Neu status.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Integrative Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Lilian Jara”